Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Early diagnosis leads King Charles to scale back cancer treatment in the new year - 2Cyclone causes blackout, flight chaos in Brazil's Sao Paulo
- 3Best Pizza Beating: What's Your #1?
- 4Figure out How to Adjust Work, Life, and an Internet based Degree
- 5Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay
- Israel's ban on unsupervised reporters in Gaza causes strategic harm to legitimacy
- Monetary Versatility: Get ready for Life's Unforeseen Difficulties
- A company is trying to unlock a key to aging, in a long-overlooked body part
- Doctor's orders? ‘Belly laugh at least two to five days a week'
- Grasping the Commencement of Criminal Cases: An Extensive Outline
- A definitive Handbook for Securities exchange Money management
- Russia accidentally destroys its only way of sending astronauts to space
- Israel says soldiers wounded in Gaza fighting amid fragile truce
- 6 Objections for an Ocean side Wedding
